Coya Therapeutics Inc (COYA)
8.79
+0.29
(+3.41%)
USD |
NASDAQ |
May 17, 16:00
8.79
0.00 (0.00%)
After-Hours: 20:00
Coya Therapeutics 1 Year Total Returns (Daily): 51.56% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | 51.56% |
| May 16, 2024 | 45.80% |
| May 15, 2024 | 58.49% |
| May 14, 2024 | 57.44% |
| May 13, 2024 | 54.20% |
| May 10, 2024 | 53.46% |
| May 09, 2024 | 61.14% |
| May 08, 2024 | 52.66% |
| May 07, 2024 | 55.77% |
| May 06, 2024 | 60.38% |
| May 03, 2024 | 78.97% |
| May 02, 2024 | 91.70% |
| May 01, 2024 | 85.26% |
| April 30, 2024 | 87.75% |
| April 29, 2024 | 73.85% |
| April 26, 2024 | 85.75% |
| April 25, 2024 | 78.79% |
| April 24, 2024 | 77.43% |
| April 23, 2024 | 70.63% |
| April 22, 2024 | 70.00% |
| April 19, 2024 | 89.57% |
| April 18, 2024 | 116.4% |
| April 17, 2024 | 107.0% |
| April 16, 2024 | 105.3% |
| April 15, 2024 | 110.3% |
| Date | Value |
|---|---|
| April 12, 2024 | 122.4% |
| April 11, 2024 | 122.8% |
| April 10, 2024 | 138.8% |
| April 09, 2024 | 122.1% |
| April 08, 2024 | 129.0% |
| April 05, 2024 | 150.6% |
| April 04, 2024 | 134.9% |
| April 03, 2024 | 144.7% |
| April 02, 2024 | 150.2% |
| April 01, 2024 | 146.6% |
| March 28, 2024 | 152.4% |
| March 27, 2024 | 141.9% |
| March 26, 2024 | 118.0% |
| March 25, 2024 | 118.2% |
| March 22, 2024 | 141.2% |
| March 21, 2024 | 150.9% |
| March 20, 2024 | 146.5% |
| March 19, 2024 | 137.5% |
| March 18, 2024 | 132.5% |
| March 15, 2024 | 114.6% |
| March 14, 2024 | 117.4% |
| March 13, 2024 | 106.1% |
| March 12, 2024 | 95.87% |
| March 11, 2024 | 112.2% |
| March 08, 2024 | 100.9% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
16.46%
Minimum
Jan 16 2024
152.4%
Maximum
Mar 28 2024
84.78%
Average
78.97%
Median
May 03 2024
1 Year Total Returns (Daily) Benchmarks
| Virpax Pharmaceuticals Inc | -90.53% |
| CEL-SCI Corp | -52.96% |
| AIM ImmunoTech Inc | -19.40% |
| IGC Pharma Inc | 69.70% |
| NovaBay Pharmaceuticals Inc | -83.53% |